Results 101 to 110 of about 22,657 (185)

Coxitis in early axial spondyloarthritis

open access: yesСовременная ревматология, 2019
In Russia, coxitis is one of the most common extra-axial manifestations of ankylosing spondylitis (AS). However, many issues regarding its early diagnosis remain unresolved.Objective: to compare the clinical manifestations of coxitis with the data from ...
E. M. Agafonova   +5 more
doaj   +1 more source

Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis

open access: yesImmunoTargets and Therapy, 2021
Fabiola Atzeni,1 Antonio Carriero,2,3 Laura Boccassini,4 Salvatore D’Angelo2 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy; 2Rheumatology Institute of Lucania (IReL), Rheumatology ...
Atzeni F   +3 more
doaj  

Differential diagnosis of axial spondyloarthritis and psoriatic arthritis with axial involvement

open access: yesСовременная ревматология
Objective: To analyze clinical and imaging characteristics of patients with axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) with spinal involvement (axial PsA, axPsA) and to develop principles for the differential diagnosis between axPsA ...
E. E. Gubar   +13 more
doaj   +1 more source

Similarities and differences: disentangling the intersection between axial psoriatic arthritis and axial spondyloarthritis

open access: yesTherapeutic Advances in Musculoskeletal Disease
Spondyloarthritis is a group of chronic inflammatory diseases that includes axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA). AxSpA primarily affects the axial skeleton, manifesting with hallmark features such as inflammatory back pain and a
Murat Torgutalp   +2 more
doaj   +1 more source

Higher body mass index and anti-drug antibodies predict the discontinuation of anti-TNF agents in Korean patients with axial spondyloarthritis

open access: yesRevista Brasileira de Reumatologia
Objective: The development of anti-drug antibodies against tumor necrosis factor inhibitors is a likely explanation for the failure of TNF-inhibitors in patients with spondyloarthritis.
Jiwon Hwang   +7 more
doaj   +1 more source

Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis.

open access: yesPLoS ONE, 2019
ObjectivesTo compare drug survival in patients with axial spondyloarthritis treated with different TNF inhibitors in standard dosage.MethodsPatients fulfilling the Assessment in SpondyloArthritis international Society classification criteria for axial ...
Monika Hebeisen   +8 more
doaj   +1 more source

Rheumatoid arthritis and spondyloarthropathy [PDF]

open access: yes, 2013
Part 2 of the article can be found through this link: https://www.um.edu.mt/library/oar//handle/123456789/13280Rheumatoid arthritis (RA) and spondyloarthropathy are two groups of inflammatory joint disease.
Vassallo, Pierre
core  

Sacroiliac and spine imaging in spondyloarthritis: Does phenotype or sex matter?

open access: yesAdvances in Rheumatology
Background Spondyloarthritis (SpA) encompasses a spectrum of immune-mediated inflammatory conditions primarily affecting the axial skeleton, including sacroiliitis and spondylitis, each with distinct features.
Gabriel Caetano Pereira   +5 more
doaj   +1 more source

South African Rheumatism and Arthritis Association 2024 guidelines for the management of peripheral spondyloarthritis

open access: yesSouth African Medical Journal
Peripheral spondyloarthritis (SpA) includes psoriatic arthritis (PsA), inflammatory bowel disease (IBD)-associated arthritis, reactive arthritis and undifferentiated peripheral SpA.
R Benitha   +7 more
doaj   +1 more source

Etanercept in axial spondyloarthritis

open access: yesChinese Medical Journal, 2022
Gui Luo, Jian Zhu, Lishao Guo
doaj   +1 more source

Home - About - Disclaimer - Privacy